Smoking prevalence and intensity in non-organized male population with cardiovascular disease
Abstract
Aim. To study tobacco smoking prevalence and intensity in working-age Tumen City men with diagnosed cardiovascular disease (CVD).
Material and methods. A representative sample of 25-64-year-old men to undergo cardiac screening was randomly selected from Tumen City voting lists. The examination included two blood pressure (BP) measurements and registration electrocardiogram, with Minnesota coding. Smoking survey was performed according to the WHO protocol.
Results. The prevalence of coronary heart disease (CHD) was 11,7%, arterial hypertension (AH) – 50,4%. In CHD men, the percentage of occasional smokers was reduced, and the percentage of ex-smokers was increased. In AH men, regular smoking rates and higher smoking intensity were observed. Increased smoking intensity was associated with significantly elevated systolic BP (SBP), and in higher smoking intensity group – also with increased diastolic BP, mostly among AH patients. In all population, smoking intensity directly correlated with mean SBP level, in 35-44-year-olds.
Conclusion. The results obtained should be used for complex CVD prevention in open Tumen City population, with prevention programs based on behavioral risk factor control by both population and high-risk strategies.
About the Authors
E. V. Akimova
Tumen Cardiology Center, Tomsk Research Institute of Cardiology, Siberian Branch, Russian Academy of Medical Sciences, Tumen; Laboratory of Cardiovascular Disease Epidemiology in Siberia; Siberian Branch, Russian Academy of Medical Sciences, Sakha Republic Government, Yakutsk
Russian Federation
Russian Federation
V. A. Kusnetsov
Tumen Cardiology Center, Tomsk Research Institute of Cardiology, Siberian Branch, Russian Academy of Medical Sciences, Tumen
Russian Federation
Russian Federation
V. V. Gafarov
Laboratory of Cardiovascular Disease Epidemiology in Siberia; Siberian Branch,
Russian Academy of Medical Sciences, Sakha Republic Government, Yakutsk
Russian Federation
Russian Federation
M. M. Kayumova
Tumen Cardiology Center, Tomsk Research Institute of Cardiology, Siberian Branch, Russian Academy of Medical Sciences, Tumen; Laboratory of Cardiovascular Disease Epidemiology in Siberia; Siberian Branch, Russian Academy of Medical Sciences, Sakha Republic Government, Yakutsk
Russian Federation
Russian Federation
V. Yu. Smaznov
Tumen Cardiology Center, Tomsk Research Institute of Cardiology, Siberian Branch, Russian Academy of Medical Sciences, Tumen
Russian Federation
Russian Federation
References
1. McBride PE. The health consequences of smoking. Cardiovascular diseases. Med Clin North Am 1992; 76: 333-53.
2. Pyorala K, De Backer G, Graham I. Prevention of coronary heart disease in clinical practice: recommendations of the Task Force of the European Society, European Atherosclerosis Society and European Society of Hypertension. Atherosclerosis 1994; 110: 121-61.
3. Zhu B, Parmley WW. Hemodynamic and vascular effect of active and passive smoking. Am Heart J 1995; 130: 1270-5.
4. Wilhelmsen L. Coronary heart disease: Epidemiology of smoking and intervention studies of smoking. Am Heart J 1988; 11-: 242-9.
5. Жуковский Г.С., Глазунов И.С., Деев А.Д. Курение и риск развития ИБС. Кардиология 1987; 1: 11-4.
6. Barua RS, Ambrose JA, Saha DC, Eales-Reynolds L-J. Smoking is associated with altered endothelial-derived fibrinolitic and antitrombotic factors. Circulation 2002; 20: 905-8.
7. Barry J, Mead K, Nabel EG. Effect of smoking on the activity of ischemic heart disease. JAMA 1989; 261(3): 398-402.
8. Оганов Р.Г., Деев А.Д., Жуковский Г.С. и др. Влияние курения на смертность от хронических неинфекционных заболеваний по результатам проспективного исследования. Профил забол укреп здор 1998; 3: 13-5.
9. Kannel W. Some lesions in cardiovascular epidemiology from Fremingham. Am J Cardiol 1976; 37: 269-82.
10. Kannel W. Quest for an optimal population cardiovascular risk factor burden. Eur Heart J 2001; 22: 105-7.
11. Paffenbarger RS, Hyde RT, Wing AL, Steinmetz CH. A natural history of athleticism and cardiovascular health. JAMA 1984; 252: 491-5.
12. Friedman GD, Dales LG, Ury HK. Mortality in middle-aged smokers and nonsmokers. Akad Med 1979; 300: 213-7.
13. Metz L, Waters DD. Implications of cigarette smoking for the management of patients with acute coronary syndromes. Prog Cardiovasc Dis 2003; 46(1): 1-9.
14. Multifactorial trial in the prevention of coronary heart disease: 3. Incidence and mortality results. WHO. Euro collaborative group. Eur Heart J 1983; 4: 141-7.
15. Чазова Л.В., Глазунов И.С., Олейников С.П., Шишова А.М. Профилактика ишемической болезни сердца. Москва 1983; 131 с.
16. Абина Е.А., Волож О.И., Солодкая Э.С. и др. Динамика распространенности ишемической болезни сердца и основных факторов риска у населения Таллинна 30-54 лет с 1984 по 1994 г. Кардиология 1997; 6: 13-8.
17. Блужас Й., Реклайтене Р., Тамошюнас А. и др. Распространенность ишемической болезни сердца и показатели смертности у населения Каунаса 35-64 лет по данным проспективного исследования Кардиология, 2002, 2, 72-5.
18. Гафаров В.В., Пак В.А., Гагулин И.В., Гафарова А.В. Эпидемиология и профилактика хронических неинфекционных заболеваний в течение 2-х десятилетий и в период социально-экономического кризиса в России. Новосибирск 2000; 284 с.
19. Реклайтене Р.А., Баубинене А.В., Домаркене С.Б. и др. Распространенность факторов риска и показатели смертности у мужчин 40-59 лет с различными формами ишемической болезни сердца (по данным 5-летнего проспективного наблюдения). Кардиология 1989; 8: 39-42.
20. Акимова Е.В., Кузнецов В.А., Гафаров В.В. Социальный градиент в Тюмени: точка зрения кардиолога. Тюмень: РГ «Проспект» 2005; 200 с.
21. Константинов В.В., Осипова О.Н., Кривошапкин В.Г., Иванов К.И. Связь ишемической болезни сердца и факторов риска среди водителей автотранспорта (по материалам одномоментного исследования). Кардиология 2001; 5: 13-7.
Review
For citations:
Akimova E.V., Kusnetsov V.A., Gafarov V.V., Kayumova M.M., Smaznov V.Yu. Smoking prevalence and intensity in non-organized male population with cardiovascular disease. Cardiovascular Therapy and Prevention. 2007;6(4):80-85. (In Russ.)
Views:
474
Email this article 
